Telonstar Tablet 40/5 mg

Adult dose

The recommended dosage for this medication is one tablet once daily, to be taken with water, regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). For patients with renal impairment, dosage adjustments are not needed for mild and moderate renal impairment, but patients with severe renal impairment should start at a lower dose and gradually increase. For patients with liver impairment, the daily dosage of telmisartan should not exceed 40 mg if the liver impairment is mild or moderate.

Child dose

The safety and efficacy of this drug in pediatric patients under the age of 18 have not been established, and its use is not recommended.

This drug can cause serious risks to the fetus during pregnancy, especially in the second and third trimesters; therefore, it should not be used by women who are pregnant or may become pregnant. Additionally, this drug should not be administered to patients with certain health conditions, such as specific liver impairment, biliary obstructive diseases, severe hypotension, and heart disease. Particular caution should be exercised in specific patient groups before taking this drug, including those with primary aldosteronism, valve stenosis, liver impairment, gastrointestinal disorders, renal artery hypertension, renal failure, and the elderly. Common side effects such as dizziness and peripheral edema may occur, and rarely, serious cardiac issues, liver function abnormalities, and skin reactions may arise, necessitating immediate consultation with a physician if abnormal symptoms occur. As this drug lowers blood pressure, appropriate measures are needed if hypotensive symptoms appear, particularly in patients with depletion of fluids or salt. Hyperkalemia may occur, so potassium levels in the blood should be regularly monitored, and caution is required when used in conjunction with potassium supplements or medications containing potassium. Patients with reduced renal function should have their kidney function and electrolyte status frequently tested, and those with heart disease should be closely monitored for blood pressure control and symptoms. This drug may cause dizziness or drowsiness when driving or operating machinery, thus caution is advised. There may be drug interactions; therefore, patients taking other medications should inform their healthcare provider, especially when taking certain analgesics, cardiac medications, or lithium. It is advisable for breastfeeding women not to take this drug, and its use is not recommended in children as safety and efficacy have not been sufficiently established. In case of overdose, symptoms may include blood pressure reduction, dizziness, and heart issues, requiring immediate medical treatment. Finally, this drug should be kept out of reach of children and taken as prescribed in terms of dosage and administration.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin reactions, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice), sudden and severe headache, thunderclap headache, seizures, altered consciousness, and visual disturbances

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory infection
• urinary tract infection
• anemia
• hyperkalemia
• hypoglycemia
• hyponatremia
• hyperglycemia
• depression

This drug is sensitive to light and should be stored in a container that blocks light. It is also safe to store between 1 and 30 degrees Celsius at room temperature. Proper storage will help maintain the drug's efficacy.

Appearance

Biconvex oval double-layer tablet colored white and light blue

Package unit

30 tablets (10 tablets/PTP*3), 30 tablets/bottle, 100 tablets/bottle